B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06769Bendamustine1Recruiting1
DB02379Beta-D-Glucose1Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB01234Dexamethasone1Completed1
DB00773Etoposide1Recruiting1
DB01073Fludarabine1Recruiting1
DB00480Lenalidomide1Suspended1
DB08935Obinutuzumab1Suspended1
DB08910Pomalidomide1Completed1
DB11581Venetoclax1Suspended1
DB02379Beta-D-Glucose1 / 2Active Not Recruiting1
DB14681Cortisone1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB00987Cytarabine1 / 2Active Not Recruiting1
DB00997Doxorubicin1 / 2Active Not Recruiting1
DB00773Etoposide1 / 2Active Not Recruiting1
DB00741Hydrocortisone1 / 2Active Not Recruiting1
DB14539Hydrocortisone acetate1 / 2Active Not Recruiting1
DB14541Hydrocortisone cypionate1 / 2Active Not Recruiting1
DB09570Ixazomib1 / 2Active Not Recruiting1
DB00563Methotrexate1 / 2Active Not Recruiting1
DB00635Prednisone1 / 2Active Not Recruiting1
DB00073Rituximab1 / 2Active Not Recruiting1
DB14546Sulfate ion1 / 2Active Not Recruiting1
DB00541Vincristine1 / 2Active Not Recruiting1